Cargando…

Investigation of HIFU-induced anti-tumor immunity in a murine tumor model

BACKGROUND: High intensity focused ultrasound (HIFU) is an emerging non-invasive treatment modality for localized treatment of cancers. While current clinical strategies employ HIFU exclusively for thermal ablation of the target sites, biological responses associated with both thermal and mechanical...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Zhenlin, Yang, Xiao Yi, Liu, Yunbo, Sankin, Georgy N, Pua, Eric C, Morse, Michael A, Lyerly, H Kim, Clay, Timothy M, Zhong, Pei
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1939831/
https://www.ncbi.nlm.nih.gov/pubmed/17625013
http://dx.doi.org/10.1186/1479-5876-5-34
_version_ 1782134405591990272
author Hu, Zhenlin
Yang, Xiao Yi
Liu, Yunbo
Sankin, Georgy N
Pua, Eric C
Morse, Michael A
Lyerly, H Kim
Clay, Timothy M
Zhong, Pei
author_facet Hu, Zhenlin
Yang, Xiao Yi
Liu, Yunbo
Sankin, Georgy N
Pua, Eric C
Morse, Michael A
Lyerly, H Kim
Clay, Timothy M
Zhong, Pei
author_sort Hu, Zhenlin
collection PubMed
description BACKGROUND: High intensity focused ultrasound (HIFU) is an emerging non-invasive treatment modality for localized treatment of cancers. While current clinical strategies employ HIFU exclusively for thermal ablation of the target sites, biological responses associated with both thermal and mechanical damage from focused ultrasound have not been thoroughly investigated. In particular, endogenous danger signals from HIFU-damaged tumor cells may trigger the activation of dendritic cells. This response may play a critical role in a HIFU-elicited anti-tumor immune response which can be harnessed for more effective treatment. METHODS: Mice bearing MC-38 colon adenocarcinoma tumors were treated with thermal and mechanical HIFU exposure settings in order to independently observe HIFU-induced effects on the host's immunological response. In vivo dendritic cell activity was assessed along with the host's response to challenge tumor growth. RESULTS: Thermal and mechanical HIFU were found to increase CD11c+ cells 3.1-fold and 4-fold, respectively, as compared to 1.5-fold observed for DC injection alone. In addition, thermal and mechanical HIFU increased CFSE+ DC accumulation in draining lymph nodes 5-fold and 10-fold, respectively. Moreover, focused ultrasound treatments not only caused a reduction in the growth of primary tumors, with tumor volume decreasing by 85% for thermal HIFU and 43% for mechanical HIFU, but they also provided protection against subcutaneous tumor re-challenge. Further immunological assays confirmed an enhanced CTL activity and increased tumor-specific IFN-γ-secreting cells in the mice treated by focused ultrasound, with cytotoxicity induced by mechanical HIFU reaching as high as 27% at a 10:1 effector:target ratio. CONCLUSION: These studies present initial encouraging results confirming that focused ultrasound treatment can elicit a systemic anti-tumor immune response, and they suggest that this immunity is closely related to dendritic cell activation. Because DC activation was more pronounced when tumor cells were mechanically lysed by focused ultrasound treatment, mechanical HIFU in particular may be employed as a potential strategy in combination with subsequent thermal ablations for increasing the efficacy of HIFU cancer treatment by enhancing the host's anti-tumor immunity.
format Text
id pubmed-1939831
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-19398312007-08-04 Investigation of HIFU-induced anti-tumor immunity in a murine tumor model Hu, Zhenlin Yang, Xiao Yi Liu, Yunbo Sankin, Georgy N Pua, Eric C Morse, Michael A Lyerly, H Kim Clay, Timothy M Zhong, Pei J Transl Med Research BACKGROUND: High intensity focused ultrasound (HIFU) is an emerging non-invasive treatment modality for localized treatment of cancers. While current clinical strategies employ HIFU exclusively for thermal ablation of the target sites, biological responses associated with both thermal and mechanical damage from focused ultrasound have not been thoroughly investigated. In particular, endogenous danger signals from HIFU-damaged tumor cells may trigger the activation of dendritic cells. This response may play a critical role in a HIFU-elicited anti-tumor immune response which can be harnessed for more effective treatment. METHODS: Mice bearing MC-38 colon adenocarcinoma tumors were treated with thermal and mechanical HIFU exposure settings in order to independently observe HIFU-induced effects on the host's immunological response. In vivo dendritic cell activity was assessed along with the host's response to challenge tumor growth. RESULTS: Thermal and mechanical HIFU were found to increase CD11c+ cells 3.1-fold and 4-fold, respectively, as compared to 1.5-fold observed for DC injection alone. In addition, thermal and mechanical HIFU increased CFSE+ DC accumulation in draining lymph nodes 5-fold and 10-fold, respectively. Moreover, focused ultrasound treatments not only caused a reduction in the growth of primary tumors, with tumor volume decreasing by 85% for thermal HIFU and 43% for mechanical HIFU, but they also provided protection against subcutaneous tumor re-challenge. Further immunological assays confirmed an enhanced CTL activity and increased tumor-specific IFN-γ-secreting cells in the mice treated by focused ultrasound, with cytotoxicity induced by mechanical HIFU reaching as high as 27% at a 10:1 effector:target ratio. CONCLUSION: These studies present initial encouraging results confirming that focused ultrasound treatment can elicit a systemic anti-tumor immune response, and they suggest that this immunity is closely related to dendritic cell activation. Because DC activation was more pronounced when tumor cells were mechanically lysed by focused ultrasound treatment, mechanical HIFU in particular may be employed as a potential strategy in combination with subsequent thermal ablations for increasing the efficacy of HIFU cancer treatment by enhancing the host's anti-tumor immunity. BioMed Central 2007-07-11 /pmc/articles/PMC1939831/ /pubmed/17625013 http://dx.doi.org/10.1186/1479-5876-5-34 Text en Copyright © 2007 Hu et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Hu, Zhenlin
Yang, Xiao Yi
Liu, Yunbo
Sankin, Georgy N
Pua, Eric C
Morse, Michael A
Lyerly, H Kim
Clay, Timothy M
Zhong, Pei
Investigation of HIFU-induced anti-tumor immunity in a murine tumor model
title Investigation of HIFU-induced anti-tumor immunity in a murine tumor model
title_full Investigation of HIFU-induced anti-tumor immunity in a murine tumor model
title_fullStr Investigation of HIFU-induced anti-tumor immunity in a murine tumor model
title_full_unstemmed Investigation of HIFU-induced anti-tumor immunity in a murine tumor model
title_short Investigation of HIFU-induced anti-tumor immunity in a murine tumor model
title_sort investigation of hifu-induced anti-tumor immunity in a murine tumor model
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1939831/
https://www.ncbi.nlm.nih.gov/pubmed/17625013
http://dx.doi.org/10.1186/1479-5876-5-34
work_keys_str_mv AT huzhenlin investigationofhifuinducedantitumorimmunityinamurinetumormodel
AT yangxiaoyi investigationofhifuinducedantitumorimmunityinamurinetumormodel
AT liuyunbo investigationofhifuinducedantitumorimmunityinamurinetumormodel
AT sankingeorgyn investigationofhifuinducedantitumorimmunityinamurinetumormodel
AT puaericc investigationofhifuinducedantitumorimmunityinamurinetumormodel
AT morsemichaela investigationofhifuinducedantitumorimmunityinamurinetumormodel
AT lyerlyhkim investigationofhifuinducedantitumorimmunityinamurinetumormodel
AT claytimothym investigationofhifuinducedantitumorimmunityinamurinetumormodel
AT zhongpei investigationofhifuinducedantitumorimmunityinamurinetumormodel